Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Obesity Surgery
Erschienen in: Obesity Surgery 8/2008

01.08.2008 | Review

Nutritional Deficiencies in Morbidly Obese Patients: A New Form of Malnutrition?

Part B: Minerals

verfasst von: Orit Kaidar-Person, Benjamin Person, Samuel Szomstein, Raul J. Rosenthal

Erschienen in: Obesity Surgery | Ausgabe 8/2008

Einloggen, um Zugang zu erhalten

Abstract

Even though in the Western world there is almost no limitation to a wide variety of food supply, nutritional deficiencies can be found in both normal-weight population and in the obese population. In this review, we examine the prevalence and manifestations of various mineral deficiencies in obese patients.
Literatur
1.
Gibson RS. The role of diet- and host-related factors in nutrient bioavailability and thus in nutrient-based dietary requirement estimates. Food Nutr Bull. 2007;28(1):S77–100.PubMed
2.
Bringhurst RF, Demay MB, Krane SM, Kronenberg HM. Bone and mineral metabolisim in health and disease. In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL, editors. Harrison’s principles of internal medicine. Vol 2. 16th ed. McGraw-Hill: Medical Publishing Devision; 2005. p. 2244–6.
3.
Reams SM. Patient education; foods high in magnesium. J Renal Nutr. 2002;12(1):60–4.CrossRef
4.
Kiss SA, Forster T, Dongo A. Absorption and effect of the magnesium content of a mineral water in the human body. J Am Coll Nutr. 2004;23(6):758S–62S.PubMed
5.
Kishore B, Thurlow V, Kessel B. Hypokalaemic rhabdomyolysis. Ann Clin Biochem. 2007;44(Pt 3):308–11.PubMedCrossRef
6.
Beckett AG, Lewis JG. Serum magnesium in diabetes mellitus. Clin Sci. 1959;18:597–604.PubMed
7.
Kekwick A, Pawan GL, Chalmers TM. Resistance to ketosis in obese subjects. Lancet. 1959;2:1157–9.PubMedCrossRef
8.
Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension. 1993;21(6 Pt 2):1024–9.PubMed
9.
Rayssiguier Y, Gueux E, Nowacki W, Rock E, Mazur A. High fructose consumption combined with low dietary magnesium intake may increase the incidence of the metabolic syndrome by inducing inflammation. Magnes Res. 2006;19(4):237–43.PubMed
10.
Sontia B, Touyz RM. Role of magnesium in hypertension. Arch Biochem Biophys. 2007;458(1):33–9.PubMedCrossRef
11.
Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys. 2007;458(1):40–7.PubMedCrossRef
12.
Sales CH, Pedrosa Lde F. Magnesium and diabetes mellitus: their relation. Clin Nutr. 2006;25(4):554–62.PubMedCrossRef
13.
Huerta MG, Roemmich JN, Kington ML, Bovbjerg VE, Weltman AL, Holmes VF, et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care. 2005;28(5):1175–81.PubMedCrossRef
14.
Walti MK, Zimmermann MB, Spinas GA, Jacob S, Hurrell RF. Dietary magnesium intake in type 2 diabetes. Eur J Clin Nutr. 2002;56(5):409–14.PubMedCrossRef
15.
Sheehan JP. Magnesium deficiency and diabetes mellitus. Magnes Trace Elem. 1991–1992;10(2–4):215–9.
16.
Gillis L, Gillis A. Nutrient inadequacy in obese and non-obese youth. Can J Diet Pract Res. 2005;66(4):237–42.PubMedCrossRef
17.
Thomson CD. Assessment of requirements for selenium and adequacy of selenium status: a review. Eur J Clin Nutr. 2004;58:391–402.PubMedCrossRef
18.
Arthur JR. The role of selenium in thyroid hormone metabolism. Can J Physiol Pharm. 1991;69:1648–52.
19.
Levander OA. Nutrition and newly emerging viral diseases: an overview. J Nutr. 1997;127:948S–50S.PubMed
20.
Longnecker MP, Taylor PR, Levander OA, Howe M, Veillon C, McAdam PA, et al. Selenium in diet, blood, and toenails in relation to human health in a seleniferous area. Am J Clin Nutr. 1991;53:1288–94.PubMed
21.
Madan AK, Orth WS, Tichansky DS, Ternovits CA. Vitamin and trace mineral levels after laparoscopic gastric bypass. Obes Surg. 2006;16(5):603–6.PubMedCrossRef
22.
Kimmons JE, Blanck HM, Tohill BC, Zhang J, Khan LK. Associations between body mass index and the prevalence of low micronutrient levels among US adults. MedGenMed. 2006;8(4):59.PubMed
23.
Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB. Homocysteine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol. 2002;31:59–70.PubMedCrossRef
24.
Gonzalez S, Huerta JM, Alvarez-Uria J, Fernandez S, Patterson AM, Lasheras C. Serum selenium is associated with plasma homocysteine concentrations in elderly humans. J Nutr. 2004;134:1736–40.PubMed
25.
Jacobs ET, Jiang R, Alberts DS, et al. Selenium and colorectal adenoma: results of a pooled analysis. J Natl Cancer Inst. 2004;96:1669–75.PubMedCrossRef
26.
Combs GF Jr. Status of selenium in prostate cancer prevention. Br J Cancer. 2004;91:195–9.PubMed
27.
Goldhaber SB. Trace element risk assessment: essentiality vs. toxicity. Regul Toxicol Pharmacol. 2003;38:232–42.PubMedCrossRef
28.
Miret S, Simpson RJ, McKie AT. Physiology and molecular biology of dietary iron absorption. Annu Rev Nutr. 2003;23:283–301.PubMedCrossRef
29.
Killip S, Bennett JM, Chambers MD. Iron deficiency anemia. Am Fam Phys. 2007;75(5):671–8.
30.
Pinhas-Hamiel O, Newfield RS, Koren I, Agmon A, Lilos P, Phillip M. Greater prevalence of iron deficiency in overweight and obese children and adolescents. Int J Obes Relat Metab Disord. 2003;27(3):416–8.PubMedCrossRef
31.
Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics. 2004;114(1):104–8.PubMedCrossRef
32.
Flancbaum L, Belsley S, Drake V, Colarusso T, Tayler E. Preoperative nutritional status of patients undergoing Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg. 2006;10(7):1033–7.PubMedCrossRef
33.
Pittler MH, Ernst E. Dietary supplements for body-weight reduction: a systematic review. Am J Clin Nutr. 2004;79(4):529–36.PubMed
34.
Vincent JB. The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent. Sports Med. 2003;33(3):213–30.PubMedCrossRef
35.
Wani S, Weskamp C, Marple J, Spry L. Acute tubular necrosis associated with chromium picolinate-containing dietary supplement. Ann Pharmacother. 2006;40(3):563–6.PubMedCrossRef
36.
Ravina A, Slezak L, Mirsky N, Bryden NA, Anderson RA. Reversal of corticosteroid-induced diabetes mellitus with supplemental chromium. Diabet Med. 1999;16(2):164–7.PubMedCrossRef
37.
Anderson RA. Chromium, glucose tolerance, and diabetes. Biol Trace Elem Res. 1992;32:19–24.PubMedCrossRef
38.
Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr. 1977;30(4):531–8.PubMed
39.
Rukgauer M, Zeyfang A. Chromium determinations in blood cells: clinical relevance demonstrated in patients with diabetes mellitus type 2. Biol Trace Elem Res. 2002;86(3):193–202.PubMedCrossRef
40.
Speetjens JK, Collins RA, Vincent JB, Woski SA. The nutritional supplement chromium(III) tris(picolinate) cleaves DNA. Chem Res Toxicol. 1999;12(6):483–7.PubMedCrossRef
41.
Stearns DM. Is chromium a trace essential metal? Biofactors. 2000;11(3):149–62.PubMed
42.
Althuis MD, Jordan NE, Ludington EA, Wittes JT. Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am J Clin Nutr. 2002;76(1):148–55.PubMed
43.
Vincent JB. The bioinorganic chemistry of chromium(III). Polyhedron. 2001;20(1–2):1–26.CrossRef
44.
Diaz ML, Watkins BA, Li Y, Anderson RA, Campbell WW. Chromium picolinate and conjugated linoleic acid do not synergistically influence diet- and exercise-induced changes in body composition and health indexes in overweight women. J Nutr Biochem. 2008;19(1):61–8.
45.
Volpe SL, Huang HW, Larpadisorn K, Lesser II. Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program. J Am Coll Nutr. 2001;20(4):293–306.PubMed
46.
Sandstead HH. Zinc nutrition in the United States. Am J Clin Nutr. 1973;26(11):1251–60.PubMed
47.
Sandstead HH. Zinc as an unrecognized limiting nutrient. Am J Clin Nutr. 1973;26(8):790–1.PubMed
48.
49.
Myung SJ, Yang SK, Jung HY, Jung SA, Kang GH, Ha HK, et al. Zinc deficiency manifested by dermatitis and visual dysfunction in a patient with Crohn’s disease. J Gastroenterol. 1998;33(6):876–9.PubMedCrossRef
50.
Boosalis MG, Solem LD, Cerra FB, Konstantinides F, Ahrenholz DH, McCall JT, et al. Increased urinary zinc excretion after thermal injury. J Lab Clin Med. 1991;118(6):538–45.PubMed
51.
Fawaz F. Zinc deficiency in surgical patients: a clinical study. JPEN J Parenter Enteral Nutr. 1985;9(3):364–9.PubMedCrossRef
52.
53.
Sandstrom B. Bioavailability of zinc. Eur J Clin Nutr. 1997;51 Suppl 1:S17–9.PubMed
54.
55.
Krasovec M, Frenk E. Acrodermatitis enteropathica secondary to Crohn’s disease. Dermatology. 1996;193:361–3.PubMedCrossRef
56.
Smidt K, Pedersen SB, Brock B, Schmitz O, Fisker S, Bendix J, et al. Zinc-transporter genes in human visceral and subcutaneous adipocytes: lean versus obese. Mol Cell Endocrinol. 2007;264(1–2):68–73.PubMedCrossRef
57.
Beletate V, El Dib RP, Atallah AN. Zinc supplementation for the prevention of type 2 diabetes mellitus. Cochrane Database Syst Rev. 2007;24(1):CD005525.
58.
Adachi Y, Yoshida J, Kodera Y, Kiss T, Jakusch T, Enyedy EA, et al. Oral administration of a zinc complex improves type 2 diabetes and metabolic syndromes. Biochem Biophys Res Commun. 2006;351(1):165–70.PubMedCrossRef
59.
Marreiro Ddo N, Geloneze B, Tambascia MA, Lerario AC, Halpern A, Cozzolino SM. Effect of zinc supplementation on serum leptin levels and insulin resistance of obese women. Biol Trace Elem Res. 2006;112(2):109–18.CrossRef
60.
Tubek S. Urinary zinc excretion is normalized in primary arterial hypertension after perindopril treatment. Biol Trace Elem Res. 2006;114(1–3):127–33.PubMedCrossRef
61.
Tubek S. Increased absorption of zinc from alimentary tract in primary arterial hypertension. Biol Trace Elem Res. 2001;83(1):31–8.PubMedCrossRef
62.
Ishikawa Y, Kudo H, Kagawa Y, Sakamoto S. Increased plasma levels of zinc in obese adult females on a weight-loss program based on a hypocaloric balanced diet. In Vivo. 2005;19(6):1035–7.PubMed
63.
Di Martino G, Matera MG, De Martino B, Vacca C, Di Martino S, Rossi F. Relationship between zinc and obesity. J Med. 1993; 24(2–3):177–83.PubMed
64.
Marreiro Ddo N, Fisberg M, Cozzolino SM. Zinc nutritional status and its relationships with hyperinsulinemia in obese children and adolescents. Biol Trace Elem Res. 2004;100(2):137–49.CrossRef
65.
Marreiro Ddo N, Fisberg M, Cozzolino SM. Zinc nutritional status in obese children and adolescents. Biol Trace Elem Res. 2002;86(2):107–22.CrossRef
66.
Chen MD, Lin PY, Sheu WH. Zinc status in plasma of obese individuals during glucose administration. Biol Trace Elem Res. 1997;60(1–2):123–9.PubMedCrossRef
67.
Chen MD, Lin PY, Lin WH, Cheng V. Zinc in hair and serum of obese individuals in Taiwan. Am J Clin Nutr. 1988;48(5):1307–9.PubMed
68.
Adachi Y, Yoshida J, Kodera Y, Kiss T, Jakusch T, Enyedy EA, et al. Oral administration of a zinc complex improves type 2 diabetes and metabolic syndromes. Biochem Biophys Res Commun. 2006;351(1):165–70.PubMedCrossRef
69.
Johnson FK, Johnson RA, Durante W, Jackson KE, Stevenson BK, Peyton KJ. Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol. 2006;290(3):R601–8.PubMed
Metadaten
Titel
Nutritional Deficiencies in Morbidly Obese Patients: A New Form of Malnutrition?
Part B: Minerals
verfasst von
Orit Kaidar-Person
Benjamin Person
Samuel Szomstein
Raul J. Rosenthal
Publikationsdatum
01.08.2008
Verlag
Springer-Verlag
Erschienen in
Obesity Surgery / Ausgabe 8/2008
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-007-9350-5

Weitere Artikel der Ausgabe 8/2008

Obesity Surgery 8/2008 Zur Ausgabe

Book Review

John H. Linner: Normandy to Okinawa—A Navy Medical Officer’s Diary and Overview of World War Two

Case Reports

Small Bowel Bypass as Treatment for Functional Gastric Obstruction

Review Article

Reproductive Considerations and Pregnancy after Bariatric Surgery: Current Evidence and Recommendations

Book Review

Mark J Watson, Daniel B Jones: Lap-band Companion Handbook

Erratum

Pressure Pulse Contour-derived Stroke Volume and Cardiac Output in the Morbidly Obese Patient

Case Report

Lap-Band Causing Left Gastric Artery Erosion Presenting with Torrential Hemorrhage

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.